Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193762 | SCV000249055 | uncertain significance | not specified | 2015-07-02 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000723604 | SCV000331371 | uncertain significance | not provided | 2016-06-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001079327 | SCV000633945 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315508 | SCV000848073 | likely benign | Inborn genetic diseases | 2016-02-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000723604 | SCV004123716 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ST3GAL3: BP4 |
Diagnostic Laboratory, |
RCV000723604 | SCV001743016 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000723604 | SCV001926880 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000723604 | SCV001971671 | likely benign | not provided | no assertion criteria provided | clinical testing |